Dr. Al-Dewik is currently the Director of Translational and Precision Medicine, a Principal Investigator at Hamad Medical Corporation (HMC), and a Professor at Kingston University, United Kingdom.
Dr. Al-Dewik was awarded his Ph.D. in Biomedical Sciences from Kingston University and St George’s Medical School, London, United Kingdom (UK) in Molecular Biology and Human Genetics. He received his postgraduate award in Cancer Biology & Therapeutics (CBT) program from Harvard Medical School (HMS), USA. He is licensed by the Ministry of Public Health in Qatar as a Clinical Scientist and by the Ministry of Health in Jordan as a Laboratory Medicine specialist. Dr. Al-Dewik actively participates in several teaching modules at Qatar University (QU) and Hamad Bin Khalifa University (HBKU) and successfully supervises several Ph.D., MSc, and BSc students to their degrees. Dr. Al-Dewik is a member of several prestigious international professional bodies, including the Society for the Study of Inborn Errors of Metabolism (SSIEM), the European Hematology Association (EHA), and the American Society of Hematology (ASH).
Dr. Al-Dewik is successfully running several research grants funded by different funding bodies, such as the Qatar National Research Fund QNRF, HMC. His major research interests are in addressing high-priority maternal and neonatal health, such as inherited genetic disorders, congenital anomalies, cancer/leukemia, and pre-term babies.
He contributes to the body of published knowledge in metabolic, genetics, and cancer with over 100 articles in peer-reviewed journals, book chapters, and abstracts.